These reports concluded that neoadjuvant chemotherapy
with bevacizumab is oncologically feasible with good response, increased tumor resectability, and improved long-term survival.
Biermann et al., "Histologic alterations from neoadjuvant chemotherapy
in high-grade extremity soft tissue sarcoma: clinicopathological correlation," The Oncologist, vol.
Endoscopic ultrasound in restaging and predicting pathological response for advanced gastric cancer patients after neoadjuvant chemotherapy
. Asia Pac J Clin Oncol 2014; 10:e28-e32.
Sentinel lymph node biopsy after neoadjuvant chemotherapy
in patients with cytologically proven node-positive breast cancer at diagnosis.
in muscle-invasive bladder cancer: Ready for prime time?
Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy
in large operable and locally advanced breast cancer in a phase II randomized trial.
In this article, we reviewed the rate of pCR from patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy
at our institution and investigated possible clinical, histological and immunohistochemical predictive and prognostic factors.
Magliocca et al., "Neoadjuvant chemotherapy
in neuroendocrine bladder cancer: a case report," American Journal of Case Reports, vol.
Characteristics of patients were all presented with clinical stage III A and stage III B at the time of initial diagnosis: 30 patients (62.5%) who were responsive to neoadjuvant chemotherapy
and 18 patients (37.5%) who were nonresponsive.
Shimizu et al., "Tumor infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy
in triple-negative breast cancer," Breast Cancer Research and Treatment, vol.
All patients were treated with standard neoadjuvant chemotherapy
. Comparison of patient characteristics between derivation and validation cohorts did not reveal any significant differences (Table 1).
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy
for unresectable liver metastases.
All patients received neoadjuvant chemotherapy
Results of a prospective randomized trial comparing neoadjuvant chemotherapy
plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
The current treatment algorithm for localized (nonmetastatic) osteosarcoma of the extremity includes neoadjuvant chemotherapy
prior to wide local excision most often with limb-salvage and reconstruction and subsequent adjuvant chemotherapy.